Age-Related Nuclear Sclerosis: What It Is, How It Progresses, and When Cataract Surgery Is Needed

What Is Age-Related Nuclear Sclerosis?

Nuclear sclerosis is the most common type of age-related cataract. It occurs when the central nucleus of the natural crystalline lens gradually hardens and yellows with age, reducing the clarity and quality of light reaching the retina. It is a normal part of ageing: almost everyone will develop some degree of nuclear sclerosis if they live long enough, though the rate of progression varies considerably between individuals.

Nuclear sclerosis is one of several types of age-related and secondary cataract. For an overview of how it compares with cortical and posterior subcapsular cataracts, see our types of cataracts guide.

What Causes Nuclear Sclerosis?

The crystalline lens is avascular, meaning it receives no direct blood supply and depends on diffusion for nutrition. Over decades, the central lens fibres compact and undergo chemical changes including protein cross-linking and pigmentation, producing progressive yellowing and hardening of the nucleus.

Risk factors that accelerate nuclear sclerosis include ultraviolet light exposure, smoking, diabetes, corticosteroid use, and family history. Most nuclear sclerosis, however, is simply a consequence of ageing rather than a specific identifiable cause.

What Are the Symptoms of Nuclear Sclerosis?

Nuclear sclerosis produces a characteristic set of symptoms that develop gradually over months to years:

• Gradual blurring of distance vision — typically the first symptom noticed.
• Reduced contrast sensitivity — difficulty distinguishing objects against similar backgrounds, particularly in dim light or at dusk.
• Glare and halos around lights at night — particularly from oncoming headlights.
• Yellowing of colour perception — whites appear yellow and blues appear muted.
• "Second sight" — a paradoxical temporary improvement in reading vision that occurs early in nuclear sclerosis as the increasing lens power shifts refraction toward myopia. This is often misinterpreted as an improvement in vision, but it represents early lens change rather than a genuine benefit.
• Progressive myopic shift — patients may need increasingly stronger glasses prescriptions for distance as the lens continues to change.

How Is Nuclear Sclerosis Graded?

The standard clinical grading system used by ophthalmologists is the Lens Opacities Classification System III (LOCS III). Nuclear opalescence (NO) and nuclear colour (NC) are each graded from 0.1 to 6.9 by comparison with standardised photographs at the slit lamp. Grading helps standardise documentation between examinations and between clinicians, but the decision to proceed with surgery is based on functional impact rather than grading alone.

Dense nuclear sclerosis, typically graded LOCS III NO 4 or above, increases surgical difficulty. A hard nucleus requires more phacoemulsification ultrasound energy to remove, which is one of several reasons earlier surgical timing is generally preferred over waiting for a cataract to become very dense.

How Is Nuclear Sclerosis Different From Other Types of Cataracts?

Nuclear sclerosis affects the central lens and progresses gradually, typically affecting distance vision first. This differs from a cortical cataract, which produces spoke-like opacities in the lens periphery and causes glare, and from a posterior subcapsular cataract (PSC), which forms at the back of the lens, is more common in younger patients, steroid users, and diabetics, and causes marked near vision difficulty and glare that can be disproportionate to the measured loss of visual acuity. For a full comparison of these cataract types, see our types of cataracts guide.

When Is Surgery Needed for Nuclear Sclerosis?

The decision to proceed with cataract surgery is based on functional impact, how much the cataract is affecting daily life, not on the degree of opacity alone. Surgery is generally recommended when nuclear sclerosis is causing difficulty with driving, reading, recognising faces, or other activities important to the patient, and when spectacle correction can no longer adequately compensate.

There is no benefit to waiting for a cataract to become "ripe". Modern phacoemulsification is effective at all stages of nuclear sclerosis, and very dense cataracts (hypermature nuclear sclerosis) are actually more surgically challenging. For guidance on assessing whether your symptoms warrant a referral, see our guide on how to know if you need cataract surgery.

What Happens During Surgery for Nuclear Sclerosis?

Phacoemulsification uses ultrasonic energy to break up and aspirate the hardened nucleus, which is then replaced with an artificial intraocular lens. Denser cataracts require more phacoemulsification energy, which is one reason operating before the cataract becomes extremely dense tends to produce better outcomes and lower complication rates. See our cataract surgery guide for a full explanation of the procedure.

Dr Ross MacIntyre has performed over 7,000 cataract surgeries, with subspecialty fellowship training in complex cataract surgery from the Wilmer Eye Institute, Johns Hopkins University. For more on his surgical experience with dense and complex cataracts, see the profile at drmacintyre.com/cataract-surgery-melbourne.

After surgery, the thin capsule that supported the natural lens is left in place to support the new IOL. In a proportion of patients this capsule can become cloudy over subsequent months or years, a separate condition called posterior capsule opacification. This is not a recurrence of the cataract and is treated with a brief in-rooms laser procedure. See our guide to YAG capsulotomy and posterior capsule opacification for detail.

Can Nuclear Sclerosis Be Prevented or Slowed?

There is no proven medical treatment that reverses or halts nuclear sclerosis. UV protection with quality sunglasses outdoors, not smoking, good diabetic control, and avoiding prolonged corticosteroid use where clinically possible may help reduce the rate of progression. Eye drop treatments marketed as "anti-cataract" drops have no proven efficacy in peer-reviewed trials for age-related nuclear sclerosis.

A referral from your GP or optometrist is required to see Dr MacIntyre. I consult at Northern Eye Consultants in Bundoora and at Bass Coast Eye Centre in Wonthaggi.

References

1. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. Arch Ophthalmol. 1993;111(6):831–836.
2. American Academy of Ophthalmology. Cataract in the Adult Eye, Preferred Practice Pattern. San Francisco: AAO; 2021.
3. Gupta VB, Rajagopala M, Ravishankar B. Etiopathogenesis of cataract: an appraisal. Indian J Ophthalmol. 2014;62(2):103–110.

Dr Ross MacIntyre BA (Chemistry) MD FRANZCO is a cataract, corneal and refractive surgeon practising in Melbourne, with over 7,000 cataract surgeries performed. He completed subspecialty fellowship training in cornea, complex cataract and refractive surgery at the Wilmer Eye Institute, Johns Hopkins University, and holds a public appointment at the Royal Victorian Eye and Ear Hospital. For a complete overview of cataract surgery and intraocular lens options, see corneaeyedoctor.com/cataract-surgery/.